Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. - Wikidata - awgldk - TriplyDB

Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.

Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.

http://www.wikidata.org/entity/Q37290826

about

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer.Prediction of gastric cancer metastasis through urinary metabolomic investigation using GC/MS.Predictive value of preoperative serum CCL2, CCL18, and VEGF for the patients with gastric cancer Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).Serum vascular endothelial growth factors C and D as forecast tools for patients with gallbladder carcinoma Association of plasma VEGF-A, soluble VEGFR-1 and VEGFR-2 levels and clinical response and survival in advanced colorectal cancer patients receiving bevacizumab with modified FOLFOX6.Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer.Effect and clinical significance of fast-track surgery combined with laparoscopic radical gastrectomy on the plasma level of vascular endothelial growth factor in gastric antrum cancer.Role of vascular endothelial growth factor C in classical Hodgkin lymphoma.Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinoma.125I-F56 Peptide as Radioanalysis Agent Targeting VEGFR1 in Mice Xenografted with Human Gastric Tumor.Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer.Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer.Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.Global DNA methylation and tumor suppressor gene promoter methylation and gastric cancer risk in an Omani Arab population Risk of bleeding associated with antiangiogenic monoclonal antibodies bevacizumab and ramucirumab: a meta-analysis of 85 randomized controlled trials

P2860

Q34266010-A93A99AC-84BD-4367-8CD3-A16BB204108A Q34591157-BCE1366C-5CCF-4F2E-B2C5-8479C130DCC8 Q34734529-30010DDB-B9F4-4038-921A-D779632187B6 Q35050037-220B7297-11D1-4209-8DBC-FE66BC1A8CE7 Q35760920-D787EFBE-9DD7-4878-B7E8-537F143775D3 Q35987896-DD2411AC-F479-4E38-B322-B0AEE2F2D50B Q36216678-50352470-4CD3-47BC-8CD0-74C1234E6E88 Q36420140-00BE11BB-68C5-4B8C-ADD9-D3BDF1F42D7A Q36484247-FF28D824-F998-486D-B77E-A0B7979CD560 Q38968332-08192A35-BE86-4D94-9B58-24BAAFF4E71B Q41791347-93A62BD8-DD91-415A-AB76-9C0F3AF99567 Q42491935-5B9D48F1-14B1-47F4-8C75-78310C57E687 Q50893285-1ED6B7AF-1B71-4A2A-BD5B-4047AF176147 Q53165141-0A3E71F1-D2C6-4676-AA78-5FF4A7D6EC78 Q54470228-6B883E12-6275-4E46-9ADE-52A3BB46426D Q54621257-8A6F3E65-ECC7-480F-BD6D-E81E039C09CA Q58317848-B957585F-DEC2-4055-8C45-E92A2580BFFE Q58729601-1CC47C5E-C63F-4928-9430-E9E9F4AD8009

P2860

Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.

http://www.wikidata.org/entity/Q37290826

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Measurement of circulating lev ...... -2 in gastric adenocarcinoma.

@en

Measurement of circulating lev ...... -2 in gastric adenocarcinoma.

@nl

type

label

Measurement of circulating lev ...... -2 in gastric adenocarcinoma.

@en

Measurement of circulating lev ...... -2 in gastric adenocarcinoma.

@nl

prefLabel

Measurement of circulating lev ...... -2 in gastric adenocarcinoma.

@en

Measurement of circulating lev ...... -2 in gastric adenocarcinoma.

@nl

P1433

Q37290826-9EE510DF-404F-4636-8DC2-DBEFC6938ED2

P1476

Q37290826-3EC19A5F-2618-468E-98E2-20FAF328092E

P2093

Q37290826-28A1CE01-2079-411A-8AD3-57281F200D2E

Q37290826-38F6F281-F15A-48CD-9C95-B25B4659A964

Q37290826-4E5AD466-350E-4FD6-89CD-4F5692934C52

Q37290826-5DCCCC48-0A21-47AF-8EA0-AD607241F539

Q37290826-64A978F3-633B-4F7A-9F11-9E35044D045C

Q37290826-DBB2A645-4185-49DA-BE50-4C01C0711316

P2860

Q37290826-082C1C50-A7ED-4027-B70E-F2420663A2CD

Q37290826-240DFCFA-419A-453F-81DE-2681154536F1

Q37290826-2F0A0DF1-12A5-494D-9FF2-16744FA2FB9F

Q37290826-3A50128A-D24C-431A-BA59-6F04093A7159

Q37290826-59A33AA6-2D1F-4D5F-8441-1355009494C4

Q37290826-73CE481D-B653-421F-AB3F-DA7A506652EB

Q37290826-88D0C44C-33FC-42E0-BE6D-60B0613B6EA8

Q37290826-94D05165-3BC0-4242-8304-DD860A059267

Q37290826-A893C5A8-48D9-4A1D-B298-63634CAC72E1

Q37290826-AEA4E91D-3B9C-4BFE-9B5B-748A5CD59D75

P304

Q37290826-7D243C11-9AC5-4825-81EE-BCDE5AFFD2A9

P31

Q37290826-E7238724-5E79-48FE-B88C-C1293158C021

P356

Q37290826-FAF7622A-3452-4F3E-8494-74BFD5DFC49B

P407

Q37290826-C3D04AB6-512C-4B15-A0D4-7B3688F17DF1

P433

Q37290826-03A4FC26-50B4-4781-A54E-638395E55E08

P478

Q37290826-DF3157F6-4BAC-4FBA-A9CF-317E91AF60BC

P50

Q37290826-69F148AE-BACF-44CE-A766-02F17545F9AA

P577

Q37290826-423275B0-5638-4E9D-B3CD-B3B06E406FE1

P698

Q37290826-D58347CF-0B68-4833-A014-15D985D356EC

P921

Q37290826-1CFDA950-6173-4A67-BA9F-52D1D3CCD18A

P932

Q37290826-31FF6EBB-3514-4E19-BE76-51497955816B

P356

P1433

World Journal of Gastroenterology

P1476

Measurement of circulating lev ...... d -2 in gastric adenocarcinoma

@en

P2093

A Rizivi

http://www.w3.org/2001/XMLSchema#string

B Al-Bahrani

http://www.w3.org/2001/XMLSchema#string

I-A Burney

http://www.w3.org/2001/XMLSchema#string

M Al-Nabhani

http://www.w3.org/2001/XMLSchema#string

Mansour-S Al-Moundhri

http://www.w3.org/2001/XMLSchema#string

S-S Ganguly

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 years.

Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.

Microvessel density is a prognostic marker of human gastric cancer.

Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer.

A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?

Molecular markers for gastric adenocarcinoma: an update.

Vascular endothelial growth factor family of ligands and receptors: review.

Vascular endothelial growth factor (VEGF) inhibition--a critical review.

Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.

VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression.

P304

3879-3883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.14.3879

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Ahmed K Al-Shukaili

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18609713

http://www.w3.org/2001/XMLSchema#string

P921

P932

2721446

http://www.w3.org/2001/XMLSchema#string